FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1594820532> ?p ?o ?g. }

• W1594820532 endingPage "439" @default.
• W1594820532 startingPage "428" @default.
• W1594820532 abstract "Direct vaccination with mRNA encoding tumor antigens is a novel and promising approach in cancer immunotherapy. CureVac's mRNA vaccines contain free and protamine-complexed mRNA. Such two-component mRNA vaccines support both antigen expression and immune stimulation. These self-adjuvanting RNA vaccines, administered intradermally without any additional adjuvant, induce a comprehensive balanced immune response, comprising antigen specific CD4+ T cells, CD8+ T cells and B cells. The balanced immune response results in a strong anti-tumor effect and complete protection against antigen positive tumor cells. This tumor inhibition elicited by mRNA vaccines is a result of the concerted action of different players. After just two intradermal vaccinations, we observe multiple changes at the tumor site, including the up-regulation of many genes connected to T and natural killer cell activation, as well as genes responsible for improved infiltration of immune cells into the tumor via chemotaxis. The two-component mRNA vaccines induce a very fast and boostable immune response. Therefore, the vaccination schedules can be adjusted to suit the clinical situation. Moreover, by combining the mRNA vaccines with therapies in clinical use (chemotherapy or anti-CTLA-4 antibody therapy), an even more effective anti-tumor response can be elicited. The first clinical data obtained from two separate Phase I/IIa trials conducted in PCA (prostate cancer) and NSCLC (non-small cell lung carcinoma) patients have shown that the two-component mRNA vaccines are safe, well tolerated and highly immunogenic in humans. Copyright © 2012 John Wiley & Sons, Ltd." @default.
• W1594820532 created "2016-06-24" @default.
• W1594820532 creator A5001797354 @default.
• W1594820532 creator A5023371681 @default.
• W1594820532 creator A5039481797 @default.
• W1594820532 creator A5057935520 @default.
• W1594820532 creator A5062384408 @default.
• W1594820532 creator A5065714330 @default.
• W1594820532 creator A5081842486 @default.
• W1594820532 date "2012-06-01" @default.
• W1594820532 modified "2023-10-16" @default.
• W1594820532 title "Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect" @default.
• W1594820532 cites W143964993 @default.
• W1594820532 cites W1556742536 @default.
• W1594820532 cites W177579774 @default.
• W1594820532 cites W1963939177 @default.
• W1594820532 cites W1965119596 @default.
• W1594820532 cites W1981851073 @default.
• W1594820532 cites W1986441039 @default.
• W1594820532 cites W1989823046 @default.
• W1594820532 cites W1990013942 @default.
• W1594820532 cites W2005765588 @default.
• W1594820532 cites W2009241266 @default.
• W1594820532 cites W2013183060 @default.
• W1594820532 cites W2013224779 @default.
• W1594820532 cites W2014365984 @default.
• W1594820532 cites W2014992495 @default.
• W1594820532 cites W2015466920 @default.
• W1594820532 cites W2018311806 @default.
• W1594820532 cites W2018653467 @default.
• W1594820532 cites W2019752350 @default.
• W1594820532 cites W2021175628 @default.
• W1594820532 cites W2029744149 @default.
• W1594820532 cites W2031821489 @default.
• W1594820532 cites W2042965540 @default.
• W1594820532 cites W2047902191 @default.
• W1594820532 cites W2048356142 @default.
• W1594820532 cites W2048657818 @default.
• W1594820532 cites W2048916379 @default.
• W1594820532 cites W2053061663 @default.
• W1594820532 cites W2054178856 @default.
• W1594820532 cites W2056893124 @default.
• W1594820532 cites W2064789528 @default.
• W1594820532 cites W2066847748 @default.
• W1594820532 cites W2069087118 @default.
• W1594820532 cites W2069274376 @default.
• W1594820532 cites W2069372863 @default.
• W1594820532 cites W2080439368 @default.
• W1594820532 cites W2087686362 @default.
• W1594820532 cites W2089493370 @default.
• W1594820532 cites W2093679073 @default.
• W1594820532 cites W2096151993 @default.
• W1594820532 cites W2096449627 @default.
• W1594820532 cites W2096866753 @default.
• W1594820532 cites W2100745065 @default.
• W1594820532 cites W2101663915 @default.
• W1594820532 cites W2112069616 @default.
• W1594820532 cites W2112471653 @default.
• W1594820532 cites W2118761956 @default.
• W1594820532 cites W2119209952 @default.
• W1594820532 cites W2120292596 @default.
• W1594820532 cites W2125821230 @default.
• W1594820532 cites W2132503390 @default.
• W1594820532 cites W2136572822 @default.
• W1594820532 cites W2137545053 @default.
• W1594820532 cites W2140683554 @default.
• W1594820532 cites W2141675109 @default.
• W1594820532 cites W2142300779 @default.
• W1594820532 cites W2142302700 @default.
• W1594820532 cites W2142540954 @default.
• W1594820532 cites W2148379111 @default.
• W1594820532 cites W2158252423 @default.
• W1594820532 cites W2164918836 @default.
• W1594820532 cites W2165903695 @default.
• W1594820532 cites W2166752790 @default.
• W1594820532 cites W2167888501 @default.
• W1594820532 cites W2167973264 @default.
• W1594820532 cites W2169794517 @default.
• W1594820532 doi "https://doi.org/10.1002/jgm.2605" @default.
• W1594820532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22262664" @default.
• W1594820532 hasPublicationYear "2012" @default.
• W1594820532 type Work @default.
• W1594820532 sameAs 1594820532 @default.
• W1594820532 citedByCount "88" @default.
• W1594820532 countsByYear W15948205322012 @default.
• W1594820532 countsByYear W15948205322013 @default.
• W1594820532 countsByYear W15948205322014 @default.
• W1594820532 countsByYear W15948205322015 @default.
• W1594820532 countsByYear W15948205322016 @default.
• W1594820532 countsByYear W15948205322017 @default.
• W1594820532 countsByYear W15948205322018 @default.
• W1594820532 countsByYear W15948205322019 @default.
• W1594820532 countsByYear W15948205322020 @default.
• W1594820532 countsByYear W15948205322021 @default.
• W1594820532 countsByYear W15948205322022 @default.
• W1594820532 countsByYear W15948205322023 @default.
• W1594820532 crossrefType "journal-article" @default.
• W1594820532 hasAuthorship W1594820532A5001797354 @default.

• next